Winslow Evans & Crocker’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,282
Closed -$406K 1177
2018
Q1
$406K Buy
5,282
+150
+3% +$11.1K 0.13% 157
2017
Q4
$350K Buy
5,132
+4,794
+1,418% +$318K 0.11% 190
2017
Q3
$21.1K Buy
338
+1
+0.3% +$60 0.01% 642
2017
Q2
$18.7K Sell
337
-13
-4% -$677 0.01% 761
2017
Q1
$17.6K Buy
350
+104
+42% +$5.07K 0.01% 758
2016
Q4
$12.1K Sell
246
-8,224
-97% -$417K ﹤0.01% 837
2016
Q3
$444K Buy
8,470
+8,224
+3,343% +$403K 0.13% 169
2016
Q2
$11K Sell
246
-67
-21% -$2.91K ﹤0.01% 851
2016
Q1
$12.8K Sell
313
-89
-22% -$3.28K ﹤0.01% 822
2015
Q4
$14.6K Buy
402
+16
+4% +$579 ﹤0.01% 819
2015
Q3
$12.7K Buy
+386
New +$13K ﹤0.01% 835

Other funds holding XYL

Winslow Evans & Crocker's XYL Position: Q2 2018 in Review

Winslow Evans & Crocker sold out of Xylem (XYL) in Q2 2018, closing a stake of 5,282 shares — an estimated $406K sold.

Winslow Evans & Crocker first reported a position in XYL in Q3 2015 and held it in 11 quarters. The position peaked at $444K in Q3 2016. 644 funds tracked by Wall St. Rank hold XYL as of Q2 2018.

  • Winslow Evans & Crocker reported no remaining Xylem position as of Q2 2018 after selling out during the quarter.
  • Winslow Evans & Crocker sold 5,282 Xylem shares in Q2 2018, an estimated $406K.
  • Winslow Evans & Crocker first reported a position in Xylem in Q3 2015 and held it in 11 quarters.
  • Winslow Evans & Crocker's Xylem position peaked at $444K in Q3 2016.
  • 644 funds tracked by Wall St. Rank held Xylem as of Q2 2018.

Based on Winslow Evans & Crocker's 13F filing for Q2 2018, filed 17 Jul 2018.